Autophagy-mediated drug resistance of non-small cell Lung cancer
碩士 === 國立中興大學 === 生命科學系所 === 107 === Non-small cell lung cancer (NSCLC) often develops multiple drug resistance during chemotherapy, which has become the biggest obstacle for clinical treatment of lung cancer. Rosiglitazone (ROSI) is a PPAR-γ agonist and has been used in diabetes and cancer treatmen...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2019
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/47rzfx |